World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
26514
World Ranking
9816
National Ranking
5047

George J. Bosl publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where George J. Bosl sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 397 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

George J. Bosl D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where George J. Bosl sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 96 D-Index — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

George J. Bosl is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research primarily focuses on medicine, with particular emphasis on surgery, pulmonary and respiratory medicine, hematology, reproductive medicine, and neurology.

Their work revolves around several key topics including testicular diseases and treatments, ovarian cancer diagnosis and treatment, neuroblastoma research and treatments, sarcoma diagnosis and treatment, multiple myeloma research and treatments, lung cancer research studies, and acute myeloid leukemia research.

George J. Bosl has contributed to numerous publications across various journals. Frequent venues for their work include:

  • Journal of Clinical Oncology
  • The Annals of Thoracic Surgery
  • Journal of Clinical Investigation
  • The Oncologist
  • JCO Precision Oncology

Significant recent papers authored or co-authored by George J. Bosl are:

  • "Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor," 2020, Journal of Clinical Investigation
  • "Adjuvant Chemotherapy With Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors," 2020, Journal of Clinical Oncology
  • "Four Cycles of Etoposide plus Cisplatin for Patients with Good-Risk Advanced Germ Cell Tumors," 2021, The Oncologist
  • "Germ Cell Tumor Molecular Heterogeneity Revealed Through Analysis of Primary and Metastasis Pairs," 2020, JCO Precision Oncology
  • "Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease," 2024, Journal of Clinical Oncology

Frequent collaborators include:

  • Samuel A. Funt
  • Darren R. Feldman
  • Joel Sheinfeld
  • Deaglan Joseph McHugh
  • Dean F. Bajorin

Best Publications

  • Testicular Germ-Cell Cancer

    George J. Bosl;Robert J. Motzer

  • Computerized Quantitation of Synergism and Antagonism of Taxol, Topotecan, and Cisplatin Against Human Teratocarcinoma Cell Growth: a Rational Approach to Clinical Protocol Design

    Ting-Chao Chou;Robert J. Motzer;Youzhi Tong;George J. Bosl

  • Combination of Paclitaxel, Ifosfamide, and Cisplatin Is an Effective Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Tumors

    G. Varuni Kondagunta;Jennifer Bacik;Alessia Donadio;Dean Bajorin

  • Medical Treatment of Advanced Testicular Cancer

    Darren R. Feldman;George J. Bosl;Joel Sheinfeld;Robert J. Motzer

  • Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors.

    Robert J. Motzer;Alison Amsterdam;Alison Amsterdam;Victor Prieto;Victor Prieto;Joel Sheinfeld;Joel Sheinfeld

  • Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.

    Robert J. Motzer;Craig J. Nichols;Kim A. Margolin;Jennifer Bacik

  • Down-Regulation of Stem Cell Genes, Including Those in a 200-kb Gene Cluster at 12p13.31, Is Associated with In vivo Differentiation of Human Male Germ Cell Tumors

    James E. Korkola;Jane Houldsworth;Rajendrakumar S.V. Chadalavada;Adam B. Olshen

  • Raynaud's Phenomenon: A Common Toxicity After Combination Chemotherapy for Testicular Cancer

    Nicholas J. Vogelzang;George J. Bosl;Kay Johnson;B.J. Kennedy

  • A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.

    G J Bosl;N L Geller;D Bajorin;S P Leitner

  • Paclitaxel, Ifosfamide, and Cisplatin Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Cancer

    Robert J. Motzer;Joel Sheinfeld;Madhu Mazumdar;Manjit Bains

  • Long-Term and Late Effects of Germ Cell Testicular Cancer Treatment and Implications for Follow-Up

    Hege S. Haugnes;George J. Bosl;Hink Boer;Jourik A. Gietema

  • Teratoma with malignant transformation in germ cell tumors in men.

    Tauseef Ahmed;George J. Bosl;Steven I. Hajdu

  • Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion.

    Howard I. Scher;Alan Yagoda;Harry W. Herr;Cora N. Sternberg

  • Chemotherapy for Teratoma With Malignant Transformation

    Alessia C. Donadio;Robert J. Motzer;Dean F. Bajorin;Philip W. Kantoff

  • VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.

    G J Bosl;R Gluckman;N L Geller;R B Golbey

  • Improved control of cisplatin‐induced emesis with high‐dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients

    Mark G. Kris;Richard J. Gralla;Leslie B. Tyson;Rebecca A. Clark

  • Sequential Dose-Intensive Paclitaxel, Ifosfamide, Carboplatin, and Etoposide Salvage Therapy for Germ Cell Tumor Patients

    Robert J. Motzer;Madhu Mazumdar;Joel Sheinfeld;Dean F. Bajorin

  • TI-CE High-Dose Chemotherapy for Patients With Previously Treated Germ Cell Tumors: Results and Prognostic Factor Analysis

    Darren R. Feldman;Joel Sheinfeld;Dean F. Bajorin;Patricia Fischer

  • A method for assessing house staff workload as a function of length of stay.

    Timothy H. Dellit;Barbara Armas-Loughran;George J. Bosl;Kent A. Sepkowitz

  • Germ Cell Tumors

    Edward R. Laws;Jason P. Sheehan

Frequent Co-Authors

Robert J. Motzer
Robert J. Motzer Memorial Sloan Kettering Cancer Center
Dean F. Bajorin
Dean F. Bajorin Memorial Sloan Kettering Cancer Center
Victor E. Reuter
Victor E. Reuter Memorial Sloan Kettering Cancer Center
R. S. K. Chaganti
R. S. K. Chaganti Memorial Sloan Kettering Cancer Center
Nancy L. Geller
Nancy L. Geller National Institutes of Health
Harry W. Herr
Harry W. Herr Memorial Sloan Kettering Cancer Center
David G. Pfister
David G. Pfister Memorial Sloan Kettering Cancer Center
Howard I. Scher
Howard I. Scher Memorial Sloan Kettering Cancer Center
Manjit S. Bains
Manjit S. Bains Memorial Sloan Kettering Cancer Center
Jatin P. Shah
Jatin P. Shah Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those considering studying Medicine in the USA, exploring related online degrees can expand your career opportunities in healthcare. Many accredited programs now offer flexible pathways for working professionals or students seeking alternatives to traditional medical school.

If you’re interested in mental health, accelerated msn psychiatric np programs provide a fast track to advanced nursing roles focused on psychiatric care. These programs can be ideal for those who want to specialize in mental health support and counseling.

An online health management degree offers essential skills in healthcare leadership and operations, opening doors to managerial roles in clinics, hospitals, or health organizations.

Budget is a concern for many students, so looking into the cheapest online mha programs and cheapest dnp degrees can make advanced education more accessible without sacrificing program quality.

These online pathways can help you launch or grow a career in healthcare, whether your interests are in clinical practice, mental health, or health administration.

Best Scientists Citing George J. Bosl

Trending Scientists

Recently Published Articles